Seek Returns logo

ALHC vs. GH: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at ALHC and GH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolALHCGH
Company NameAlignment Healthcare, Inc.Guardant Health, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesHealth Care Providers & Services
Market Capitalization3.20 billion USD7.92 billion USD
ExchangeNasdaqGSNasdaqGS
Listing DateMarch 26, 2021October 4, 2018
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of ALHC and GH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ALHC vs. GH: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolALHCGH
5-Day Price Return4.39%3.62%
13-Week Price Return8.29%62.11%
26-Week Price Return9.12%48.12%
52-Week Price Return69.15%137.47%
Month-to-Date Return13.79%54.95%
Year-to-Date Return39.38%107.86%
10-Day Avg. Volume3.16M2.30M
3-Month Avg. Volume3.44M2.44M
3-Month Volatility46.05%53.02%
Beta1.201.59

Profitability

Return on Equity (TTM)

ALHC

-43.97%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

ALHC has a negative Return on Equity of -43.97%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

GH

-246.60%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

GH has a negative Return on Equity of -246.60%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

ALHC vs. GH: A comparison of their Return on Equity (TTM) against the Health Care Providers & Services industry benchmark.

Net Profit Margin (TTM)

ALHC

-1.53%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

ALHC has a negative Net Profit Margin of -1.53%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

GH

-49.93%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

GH has a negative Net Profit Margin of -49.93%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

ALHC vs. GH: A comparison of their Net Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Operating Profit Margin (TTM)

ALHC

-0.83%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

ALHC has a negative Operating Profit Margin of -0.83%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

GH

-54.54%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

GH has a negative Operating Profit Margin of -54.54%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

ALHC vs. GH: A comparison of their Operating Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Profitability at a Glance

SymbolALHCGH
Return on Equity (TTM)-43.97%-246.60%
Return on Assets (TTM)-6.05%-29.04%
Net Profit Margin (TTM)-1.53%-49.93%
Operating Profit Margin (TTM)-0.83%-54.54%
Gross Profit Margin (TTM)12.14%62.84%

Financial Strength

Current Ratio (MRQ)

ALHC

1.66

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

ALHC’s Current Ratio of 1.66 is in the upper quartile for the Health Care Providers & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

GH

3.71

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

GH’s Current Ratio of 3.71 is exceptionally high, placing it well outside the typical range for the Health Care Providers & Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.

ALHC vs. GH: A comparison of their Current Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

ALHC

2.29

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

With a Debt-to-Equity Ratio of 2.29, ALHC operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

GH

16.78

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

With a Debt-to-Equity Ratio of 16.78, GH operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

ALHC vs. GH: A comparison of their Debt-to-Equity Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Interest Coverage Ratio (TTM)

ALHC

-4.44

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

ALHC has a negative Interest Coverage Ratio of -4.44. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

GH

-150.95

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

GH has a negative Interest Coverage Ratio of -150.95. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

ALHC vs. GH: A comparison of their Interest Coverage Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Financial Strength at a Glance

SymbolALHCGH
Current Ratio (MRQ)1.663.71
Quick Ratio (MRQ)1.493.19
Debt-to-Equity Ratio (MRQ)2.2916.78
Interest Coverage Ratio (TTM)-4.44-150.95

Growth

Revenue Growth

ALHC vs. GH: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ALHC vs. GH: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ALHC

0.00%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

ALHC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

GH

0.00%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

GH currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ALHC vs. GH: A comparison of their Dividend Yield (TTM) against the Health Care Providers & Services industry benchmark.

Dividend Payout Ratio (TTM)

ALHC

0.00%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

ALHC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

GH

0.00%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

GH has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ALHC vs. GH: A comparison of their Dividend Payout Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Dividend at a Glance

SymbolALHCGH
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

ALHC

--

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

P/E Ratio data for ALHC is currently unavailable.

GH

--

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

P/E Ratio data for GH is currently unavailable.

ALHC vs. GH: A comparison of their Price-to-Earnings Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Sales Ratio (TTM)

ALHC

0.89

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

ALHC’s P/S Ratio of 0.89 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

GH

8.74

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

With a P/S Ratio of 8.74, GH trades at a valuation that eclipses even the highest in the Health Care Providers & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ALHC vs. GH: A comparison of their Price-to-Sales Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Book Ratio (MRQ)

ALHC

19.65

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

At 19.65, ALHC’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

GH

35.72

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

At 35.72, GH’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ALHC vs. GH: A comparison of their Price-to-Book Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Valuation at a Glance

SymbolALHCGH
Price-to-Earnings Ratio (TTM)----
Price-to-Sales Ratio (TTM)0.898.74
Price-to-Book Ratio (MRQ)19.6535.72
Price-to-Free Cash Flow Ratio (TTM)64.10--